• Charlie’s Holdings issued a statement backing the Trump administration’s plan to revisit FDA rules for the Premarket Tobacco Application (PMTA) process.
• The company expects this shift to speed authorizations for flavored vapes.
• Charlie’s said it has sought FDA marketing authorization since September 2020 for some tobacco-derived nicotine e-liquids.
• It has made additional filings since May 2022 for synthetic nicotine products.
• Management said it retains 678 timely filed PMTA assets following the sale of 16 PACHA brand PMTA products in 2025 to a large tobacco company.
• The company said a streamlined pathway for timely filed PMTAs could raise the value of its remaining PACHA portfolio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charlie's Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609240900PRIMZONEFULLFEED9833170) on September 24, 2026, and is solely responsible for the information contained therein.